Loading...

Boris Bastian, MD, PhD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentDermatology
Address1450 3rd Street
San Francisco CA 94158
Phone415-502-0267
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Molecular Pathology of Cancer
    NIH/NCI T32CA177555Sep 12, 2013 - Aug 31, 2018
    Role: Co-Principal Investigator
    The GNAQ pathway as a therapeutic target in uveal melanoma
    NIH/NCI R01CA142873Dec 1, 2009 - May 31, 2021
    Role: Principal Investigator
    Biomarker Discovery for the Classification of Melanoma
    NIH/NCI R01CA131524Jul 15, 2008 - May 31, 2013
    Role: Principal Investigator
    Program Project Grant
    NIH/NIAMS P01AR050440Sep 26, 2003 - Aug 31, 2010
    Role: Co-Investigator
    Classification of ambiguous melanocytic tumors
    NIH/NCI R33CA095300Sep 25, 2002 - Jul 31, 2006
    Role: Principal Investigator
    Human Melanoma: Etiology, Progression and Therapy
    NIH P01CA025874Jan 1, 1980 - Mar 31, 2016
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Chiba K, Lorbeer FK, Shain AH, McSwiggen DT, Schruf E, Oh A, Ryu J, Darzacq X, Bastian B, Hockemeyer D. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science. 2017 Aug 17. PMID: 28818973.
      View in: PubMed
    2. Shain AH, Bastian B. Filling the gaps in the genomic catalogue of melanoma subtypes. Pigment Cell Melanoma Res. 2017 Jun 28. PMID: 28656717.
      View in: PubMed
    3. Guo J, Carvajal RD, Dummer R, Hauschild A, Daud A, Bastian B, Markovic SN, Queirolo P, Arance A, Berking C, Camargo V, Herchenhorn D, Petrella TM, Schadendorf D, Sharfman W, Testori A, Novick S, Hertle S, Nourry C, Chen Q, Hodi FS. Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial. Ann Oncol. 2017 Jun 01; 28(6):1380-1387. PMID: 28327988.
      View in: PubMed
    4. Chen X, Wu Q, Depeille P, Chen P, Thornton S, Kalirai H, Coupland SE, Roose JP, Bastian B. RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma. Cancer Cell. 2017 May 08; 31(5):685-696.e6. PMID: 28486107.
      View in: PubMed
    5. Eluri M, Feneran A, Bordeaux JS, Ruben B, Ostrowski S, Bastian B, Honda K. Multiple Merkel cell carcinomas: Late metastasis or multiple primary tumors? A molecular study. JAAD Case Rep. 2017 Mar; 3(2):131-134. PMID: 28367486.
      View in: PubMed
    6. Jonsson VD, Blakely CM, Lin L, Asthana S, Matni N, Olivas V, Pazarentzos E, Gubens MA, Bastian B, Taylor BS, Doyle JC, Bivona TG. Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution. Sci Rep. 2017 Mar 13; 7:44206. PMID: 28287179.
      View in: PubMed
    7. Joseph NM, Chen YY, Nasr A, Yeh I, Talevich E, Onodera C, Bastian B, Rabban JT, Garg K, Zaloudek C, Solomon DA. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Mod Pathol. 2016 Nov 04. PMID: 27813512.
      View in: PubMed
    8. Yeh I, Tee MK, Botton T, Shain AH, Sparatta AJ, Gagnon A, Vemula SS, Garrido MC, Nakamaru K, Isoyama T, McCalmont TH, LeBoit PE, Bastian B. NTRK3 kinase fusions in Spitz tumours. J Pathol. 2016 Nov; 240(3):282-290. PMID: 27477320.
      View in: PubMed
    9. Phillips JJ, Gong H, Chen K, Joseph NM, van Ziffle J, Jin LW, Bastian B, Bollen AW, Perry A, Nicolaides T, Solomon DA, Shieh JT, et al. Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation. Acta Neuropathol. 2016 Sep 13. PMID: 27624885.
      View in: PubMed
    10. Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian B, Chen YY, Krings G. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol. 2016 Jun 3. PMID: 27255162.
      View in: PubMed
    11. Shain AH, Bastian B. From melanocytes to melanomas. Nat Rev Cancer. 2016 Jun; 16(6):345-58. PMID: 27125352.
      View in: PubMed
    12. Talevich E, Shain AH, Botton T, Bastian B. CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. PLoS Comput Biol. 2016 Apr; 12(4):e1004873. PMID: 27100738.
      View in: PubMed
    13. Merlino G, Herlyn M, Fisher DE, Bastian B, Flaherty KT, Davies MA, Wargo JA, Curiel-Lewandrowski C, Weber MJ, Leachman SA, Soengas MS, McMahon M, Harbour JW, Swetter SM, Aplin AE, Atkins MB, Bosenberg MW, Dummer R, Gershenwald JE, Halpern AC, Herlyn D, Karakousis GC, Kirkwood JM, Krauthammer M, Lo RS, Long GV, McArthur G, Ribas A, Schuchter L, Sosman JA, Smalley KS, Steeg P, Thomas NE, Tsao H, Tueting T, Weeraratna A, Xu G, Lomax R, Martin A, Silverstein S, Turnham T, Ronai ZA. The state of melanoma: challenges and opportunities. Pigment Cell Melanoma Res. 2016 Jul; 29(4):404-16. PMID: 27087480.
      View in: PubMed
    14. Shain AH, Bastian B. The Genetic Evolution of Melanoma. N Engl J Med. 2016 Mar 10; 374(10):993-6. PMID: 26962740.
      View in: PubMed
    15. Kline CN, Joseph NM, Grenert JP, van Ziffle J, Yeh I, Bastian B, Mueller S, Solomon DA. Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas. Neuro Oncol. 2016 May; 18(5):752-3. PMID: 26902849.
      View in: PubMed
    16. Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'Arrigo C, Robson A, Bastian B. The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015 Nov 12; 373(20):1926-36. PMID: 26559571.
      View in: PubMed
    17. Shain AH, Garrido M, Botton T, Talevich E, Yeh I, Sanborn JZ, Chung J, Wang NJ, Kakavand H, Mann GJ, Thompson JF, Wiesner T, Roy R, Olshen AB, Gagnon A, Gray JW, Huh N, Hur JS, Busam KJ, Scolyer RA, Cho RJ, Murali R, Bastian B. Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nat Genet. 2015 Oct; 47(10):1194-9. PMID: 26343386; PMCID: PMC4589486 [Available on 04/01/16].
    18. Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian B, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L. A caveolin-dependent and PI3K/AKT-independent role of PTEN in ß-catenin transcriptional activity. Nat Commun. 2015; 6:8093. PMID: 26307673; PMCID: PMC4560817.
    19. Sanborn JZ, Chung J, Purdom E, Wang NJ, Kakavand H, Wilmott JS, Butler T, Thompson JF, Mann GJ, Haydu LE, Saw RP, Busam KJ, Lo RS, Collisson EA, Hur JS, Spellman PT, Cleaver JE, Gray JW, Huh N, Murali R, Scolyer RA, Bastian B, Cho RJ. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. Proc Natl Acad Sci U S A. 2015 Sep 1; 112(35):10995-1000. PMID: 26286987; PMCID: PMC4568214.
    20. Singh AD, Schoenfield LA, Bastian B, Aziz HA, Marino MJ, Biscotti CV. Congenital uveal melanoma? Surv Ophthalmol. 2016 Jan-Feb; 61(1):59-64. PMID: 26277063.
      View in: PubMed
    21. Menzies AM, Yeh I, Botton T, Bastian B, Scolyer RA, Long GV. Clinical activity of the MEK inhibitor trametinib in metastatic melanoma containing BRAF kinase fusion. Pigment Cell Melanoma Res. 2015 Sep; 28(5):607-10. PMID: 26072686; PMCID: PMC4539279 [Available on 09/01/16].
    22. Machan S, Molina-Ruiz AM, Fernández-Aceñero MJ, Encabo B, LeBoit P, Bastian B, Requena L. Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings. Am J Dermatopathol. 2015 Jun; 37(6):487-94. PMID: 25062263.
      View in: PubMed
    23. Yeh I, Botton T, Talevich E, Shain AH, Sparatta AJ, de la Fouchardiere A, Mully TW, North JP, Garrido MC, Gagnon A, Vemula SS, McCalmont TH, LeBoit PE, Bastian B. Activating MET kinase rearrangements in melanoma and Spitz tumours. Nat Commun. 2015; 6:7174. PMID: 26013381; PMCID: PMC4446791.
    24. Yeh I, de la Fouchardiere A, Pissaloux D, Mully TW, Garrido MC, Vemula SS, Busam KJ, LeBoit PE, McCalmont TH, Bastian B. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol. 2015 May; 39(5):581-91. PMID: 25602801; PMCID: PMC4398593 [Available on 05/01/16].
    25. Algazi AP, Cha E, Ortiz-Urda SM, McCalmont T, Bastian B, Hwang J, Pampaloni MH, Behr S, Chong K, Cortez B, Quiroz A, Coakley F, Liu S, Daud AI. The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial. Br J Cancer. 2015 Apr 14; 112(8):1326-31. PMID: 25867272; PMCID: PMC4402449 [Available on 04/14/16].
    26. Carvajal RD, Lawrence DP, Weber JS, Gajewski TF, Gonzalez R, Lutzky J, O'Day SJ, Hamid O, Wolchok JD, Chapman PB, Sullivan RJ, Teitcher JB, Ramaiya N, Giobbie-Hurder A, Antonescu CR, Heinrich MC, Bastian B, Corless CL, Fletcher JA, Hodi FS. Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition. Clin Cancer Res. 2015 May 15; 21(10):2289-96. PMID: 25695690.
      View in: PubMed
    27. Botton T, Yeh I, Bastian B. Melanoma BRAF fusions--letter. Clin Cancer Res. 2014 Dec 15; 20(24):6631. PMID: 25512635; PMCID: PMC4270079 [Available on 12/15/15].
    28. Lowdon RF, Zhang B, Bilenky M, Mauro T, Li D, Gascard P, Sigaroudinia M, Farnham PJ, Bastian B, Tlsty TD, Marra MA, Hirst M, Costello JF, Wang T, Cheng JB. Regulatory network decoded from epigenomes of surface ectoderm-derived cell types. Nat Commun. 2014; 5:5442. PMID: 25421844; PMCID: PMC4385735.
    29. Esteve-Puig R, Gil R, González-Sánchez E, Bech-Serra JJ, Grueso J, Hernández-Losa J, Moliné T, Canals F, Ferrer B, Cortés J, Bastian B, Ramón Y Cajal S, Martín-Caballero J, Flores JM, Vivancos A, García-Patos V, Recio JÁ. A mouse model uncovers LKB1 as an UVB-induced DNA damage sensor mediating CDKN1A (p21WAF1/CIP1) degradation. PLoS Genet. 2014 Oct; 10(10):e1004721. PMID: 25329316; PMCID: PMC4199501.
    30. Luke JJ, Triozzi PL, McKenna KC, Van Meir EG, Gershenwald JE, Bastian B, Gutkind JS, Bowcock AM, Streicher HZ, Patel PM, Sato T, Sossman JA, Sznol M, Welch J, Thurin M, Selig S, Flaherty KT, Carvajal RD. Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res. 2015 Mar; 28(2):135-47. PMID: 25113308; PMCID: PMC4326637 [Available on 03/01/16].
    31. Yeh I, Mully TW, Wiesner T, Vemula SS, Mirza SA, Sparatta AJ, McCalmont TH, Bastian B, LeBoit PE. Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol. 2014 Aug; 38(8):1088-95. PMID: 24705312; PMCID: PMC4101029.
    32. North JP, Garrido MC, Kolaitis NA, LeBoit PE, McCalmont TH, Bastian B. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases. Am J Surg Pathol. 2014 Jun; 38(6):824-31. PMID: 24618603.
      View in: PubMed
    33. Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang CY, Bastian B, Zhang K, Guan KL. Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell. 2014 Jun 16; 25(6):822-30. PMID: 24882516; PMCID: PMC4075337.
    34. Menzel M, Meckbach D, Weide B, Toussaint NC, Schilbach K, Noor S, Eigentler T, Ikenberg K, Busch C, Quintanilla-Martinez L, Kohlhofer U, Göke A, Göke F, Handgretinger R, Ottmann C, Bastian B, Garbe C, Röcken M, Perner S, Kohlbacher O, Bauer J. In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival. Pigment Cell Melanoma Res. 2014 Jul; 27(4):671-3. PMID: 24703331.
      View in: PubMed
    35. North JP, Vemula SS, Bastian B. Chromosomal copy number analysis in melanoma diagnostics. Methods Mol Biol. 2014; 1102:199-226. PMID: 24258981.
      View in: PubMed
    36. Bastian B. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol. 2014; 9:239-71. PMID: 24460190.
      View in: PubMed
    37. Simpson RM, Bastian B, Michael HT, Webster JD, Prasad ML, Conway CM, Prieto VM, Gary JM, Goldschmidt MH, Esplin DG, Smedley RC, Piris A, Meuten DJ, Kiupel M, Lee CC, Ward JM, Dwyer JE, Davis BJ, Anver MR, Molinolo AA, Hoover SB, Rodriguez-Canales J, Hewitt SM. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res. 2014 Jan; 27(1):37-47. PMID: 24128326; PMCID: PMC4066658.
    38. Chen X, Wu Q, Tan L, Porter D, Jager MJ, Emery C, Bastian B. Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations. Oncogene. 2014 Sep 25; 33(39):4724-34. PMID: 24141786; PMCID: PMC4524511.
    39. Botton T, Yeh I, Nelson T, Vemula SS, Sparatta A, Garrido MC, Allegra M, Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, Burton EA, Bollag G, Ballotti R, Bastian B. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Pigment Cell Melanoma Res. 2013 Nov; 26(6):845-51. PMID: 23890088; PMCID: PMC3808507.
    40. Bastian B, Esteve-Puig R. Targeting activated KIT signaling for melanoma therapy. J Clin Oncol. 2013 Sep 10; 31(26):3288-90. PMID: 23940224.
      View in: PubMed
    41. Lyons J, Bastian B, McCormick F. MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells. Proc Natl Acad Sci U S A. 2013 Aug 20; 110(34):13845-50. PMID: 23908401; PMCID: PMC3752210.
    42. Cronin JC, Watkins-Chow DE, Incao A, Hasskamp JH, Schönewolf N, Aoude LG, Hayward NK, Bastian B, Dummer R, Loftus SK, Pavan WJ. SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis. Cancer Res. 2013 Sep 15; 73(18):5709-18. PMID: 23913827; PMCID: PMC3803156.
    43. Fleming JL, Dworkin AM, Allain DC, Fernandez S, Wei L, Peters SB, Iwenofu OH, Ridd K, Bastian B, Toland AE. Allele-specific imbalance mapping identifies HDAC9 as a candidate gene for cutaneous squamous cell carcinoma. Int J Cancer. 2014 Jan 1; 134(1):244-8. PMID: 23784969; PMCID: PMC3831612.
    44. Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, Körbel C, Laschke MW, Gimotty PA, Philipp SE, Krause E, Pätzold S, Villanueva J, Krepler C, Fukunaga-Kalabis M, Hoth M, Bastian B, Vogt T, Herlyn M. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. Cancer Cell. 2013 Jun 10; 23(6):811-25. PMID: 23764003; PMCID: PMC3810180.
    45. Yeh I, von Deimling A, Bastian B. Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia. J Natl Cancer Inst. 2013 Jun 19; 105(12):917-9. PMID: 23690527; PMCID: PMC3687371.
    46. Suri P, Bull N, Worthington A, Gunawaran P, Reeves G, Bastian B, Collins N. Audit of the aetiology and prevalence of pulmonary hypertension in a tertiary hospital setting. Intern Med J. 2013 Mar; 43(3):323-7. PMID: 23441659.
      View in: PubMed
    47. Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian B. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012 Jun; 36(6):818-30. PMID: 22367297; PMCID: PMC3354018.
    48. Murali R, Wiesner T, Rosenblum MK, Bastian B. GNAQ and GNA11 mutations in melanocytomas of the central nervous system. Acta Neuropathol. 2012 Mar; 123(3):457-9. PMID: 22307269; PMCID: PMC3495609.
    49. Griewank KG, Yu X, Khalili J, Sozen MM, Stempke-Hale K, Bernatchez C, Wardell S, Bastian B, Woodman SE. Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 2012 Mar; 25(2):182-7. PMID: 22236444; PMCID: PMC3288394.
    50. Minor DR, Kashani-Sabet M, Garrido M, O'Day SJ, Hamid O, Bastian B. Sunitinib therapy for melanoma patients with KIT mutations. Clin Cancer Res. 2012 Mar 1; 18(5):1457-63. PMID: 22261812.
      View in: PubMed
    51. Daud A, Bastian B. Beyond BRAF in melanoma. Curr Top Microbiol Immunol. 2012; 355:99-117. PMID: 21826607.
      View in: PubMed
    52. McCalmont TH, Bastian B. An unconventional deep penetrating melanocytic nevus with microscopic involvement of regional lymph nodes. J Cutan Pathol. 2012 Jan; 39(1):25-8. PMID: 22211333.
      View in: PubMed
    53. Feito-Rodríguez M, de Lucas-Laguna R, Bastian B, Leboit P, González-Beato MJ, López-Gutiérrez JC, Requena L, Pizarro A. Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi. Br J Dermatol. 2011 Nov; 165(5):1138-42. PMID: 21711345.
      View in: PubMed
    54. Jalas JR, Vemula S, Bezrookove V, Leboit PE, Simko JP, Bastian B. Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma. Am J Surg Pathol. 2011 Sep; 35(9):1413-8. PMID: 21836492; PMCID: PMC3319763.
    55. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian B, Speicher MR. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet. 2011 Oct; 43(10):1018-21. PMID: 21874003; PMCID: PMC3328403.
    56. Ahronowitz IZ, Daud AI, Leong SP, Shue EH, Bastian B, McCalmont TH, Yu SS. An isolated Merkel cell carcinoma metastasis at a distant cutaneous site presenting as a second 'primary' tumor. J Cutan Pathol. 2011 Oct; 38(10):801-7. PMID: 21883364.
      View in: PubMed
    57. Kumar SM, Zhang G, Bastian B, Arcasoy MO, Karande P, Pushparajan A, Acs G, Xu X. Erythropoietin receptor contributes to melanoma cell survival in vivo. Oncogene. 2012 Mar 29; 31(13):1649-60. PMID: 21860424; PMCID: PMC3441831.
    58. Whiteman DC, Pavan WJ, Bastian B. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res. 2011 Oct; 24(5):879-97. PMID: 21707960; PMCID: PMC3395885.
    59. North JP, Vetto JT, Murali R, White KP, White CR, Bastian B. Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma. Am J Surg Pathol. 2011 Aug; 35(8):1146-50. PMID: 21716079; PMCID: PMC4153784.
    60. Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian B, Schwartz GK. KIT as a therapeutic target in metastatic melanoma. JAMA. 2011 Jun 8; 305(22):2327-34. PMID: 21642685; PMCID: PMC3986039.
    61. Bauer J, Büttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, Scolyer RA, Bastian B. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 2011 Apr; 24(2):345-51. PMID: 21324100; PMCID: PMC3107974.
    62. McCalmont TH, Vemula S, Sands P, Bastian B. Molecular-microscopical correlation in dermatopathology. J Cutan Pathol. 2011 Apr; 38(4):324-6, 323. PMID: 21323719; PMCID: PMC3339263.
    63. Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian B. Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res. 2010 Dec; 23(6):763-70. PMID: 20874733; PMCID: PMC3107973.
    64. Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian B. Mutations in GNA11 in uveal melanoma. N Engl J Med. 2010 Dec 2; 363(23):2191-9. PMID: 21083380; PMCID: PMC3107972.
    65. Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, Ridd K, Vogel H, Bastian B, Attardi LD. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS Genet. 2010 Oct; 6(10):e1001168. PMID: 20975948; PMCID: PMC2958815.
    66. Dworkin AM, Ridd K, Bautista D, Allain DC, Iwenofu OH, Roy R, Bastian B, Toland AE. Germline variation controls the architecture of somatic alterations in tumors. PLoS Genet. 2010 Sep; 6(9):e1001136. PMID: 20885788; PMCID: PMC2944791.
    67. Griewank KG, Bastian B. Comment on "Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT". J Invest Dermatol. 2010 Sep; 130(9):2330-1; author reply 2331-2. PMID: 20711207.
      View in: PubMed
    68. Flaherty KT, Hodi FS, Bastian B. Mutation-driven drug development in melanoma. Curr Opin Oncol. 2010 May; 22(3):178-83. PMID: 20401974; PMCID: PMC3107971.
    69. Gerami P, Pouryazdanparast P, Vemula S, Bastian B. Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. Am J Dermatopathol. 2010 May; 32(3):301-5. PMID: 20110797.
      View in: PubMed
    70. Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, Bastian B. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol. 2010 Feb; 34(2):231-7. PMID: 20087158; PMCID: PMC2831773.
    71. Garrido MC, Bastian B. KIT as a therapeutic target in melanoma. J Invest Dermatol. 2010 Jan; 130(1):20-7. PMID: 19847190; PMCID: PMC2831053.
    72. Fisher DE, Barnhill R, Hodi FS, Herlyn M, Merlino G, Medrano E, Bastian B, Landi MT, Landi TM, Sosman J. Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res. 2010 Feb; 23(1):14-26. PMID: 20025711.
      View in: PubMed
    73. Ridd K, Bastian B. Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma. J Invest Dermatol. 2010 Mar; 130(3):901-3. PMID: 19812598; PMCID: PMC2825112.
    74. Yeh I, Bastian B. Genome-wide associations studies for melanoma and nevi. Pigment Cell Melanoma Res. 2009 Oct; 22(5):527-8. PMID: 19686382; PMCID: PMC2841523.
    75. Harradine KA, Ridd K, Saunier EF, Clermont FF, Perez-Losada J, Moore DH, Epstein EH, Bastian B, Akhurst RJ. Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. Clin Cancer Res. 2009 Aug 15; 15(16):5101-7. PMID: 19671862; PMCID: PMC2812428.
    76. Bauer J, Kilic E, Vaarwater J, Bastian B, Garbe C, de Klein A. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. Br J Cancer. 2009 Sep 1; 101(5):813-5. PMID: 19654573; PMCID: PMC2736834.
    77. Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, Matushek P, Legator M, Jacobson K, Dalton SR, Charzan S, Kolaitis NA, Guitart J, Lertsbarapa T, Boone S, LeBoit PE, Bastian B. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009 Aug; 33(8):1146-56. PMID: 19561450.
      View in: PubMed
    78. Bauer J, Weng J, Kebebew E, Soares P, Trovisco V, Bastian B. Germline variation of the melanocortin-1 receptor does not explain shared risk for melanoma and thyroid cancer. Exp Dermatol. 2009 Jun; 18(6):548-52. PMID: 19493000; PMCID: PMC2862686.
    79. Ridd K, Vemula S, Bastian B. Absence of somatic mutations of NEMO in keratoacanthoma. J Invest Dermatol. 2009 Oct; 129(10):2518-20. PMID: 19404319; PMCID: PMC2823812.
    80. Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X, Ridd K, Vemula S, Burrell AS, Agrawal NS, Lin JC, Banister CE, Buckhaults P, Rosenberg SA, Bastian B, Pavan WJ, Samuels Y. Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res. 2009 Aug; 22(4):435-44. PMID: 19422606; PMCID: PMC2728363.
    81. Gartside MG, Chen H, Ibrahimi OA, Byron SA, Curtis AV, Wellens CL, Bengston A, Yudt LM, Eliseenkova AV, Ma J, Curtin JA, Hyder P, Harper UL, Riedesel E, Mann GJ, Trent JM, Bastian B, Meltzer PS, Mohammadi M, Pollock PM. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol Cancer Res. 2009 Jan; 7(1):41-54. PMID: 19147536; PMCID: PMC4233648.
    82. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian B. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009 Jan 29; 457(7229):599-602. PMID: 19078957; PMCID: PMC2696133.
    83. Ridd K, Yu S, Bastian B. The presence of polyomavirus in non-melanoma skin cancer in organ transplant recipients is rare. J Invest Dermatol. 2009 Jan; 129(1):250-2. PMID: 18650847; PMCID: PMC2837873.
    84. Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, Bastian B. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med. 2008 Jun 3; 5(6):e120. PMID: 18532874; PMCID: PMC2408611.
    85. Lutzky J, Bauer J, Bastian B. Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation. Pigment Cell Melanoma Res. 2008 Aug; 21(4):492-3. PMID: 18510589.
      View in: PubMed
    86. Freedberg DE, Rigas SH, Russak J, Gai W, Kaplow M, Osman I, Turner F, Randerson-Moor JA, Houghton A, Busam K, Timothy Bishop D, Bastian B, Newton-Bishop JA, Polsky D. Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst. 2008 Jun 4; 100(11):784-95. PMID: 18505964; PMCID: PMC4410798.
    87. Fargnoli MC, Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian B, Peris K, Landi MT. MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol. 2008 Oct; 128(10):2485-90. PMID: 18368129; PMCID: PMC2835495.
    88. North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian B. Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. J Invest Dermatol. 2008 Aug; 128(8):2024-30. PMID: 18323782; PMCID: PMC2825251.
    89. Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M, Denat L, Goodall J, Luciani F, Viros A, Demirkan N, Bastian B, Goding CR, Larue L. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev. 2007 Nov 15; 21(22):2923-35. PMID: 18006687; PMCID: PMC2049194.
    90. Muchemwa FC, Ma D, Inoue Y, Curtin JA, Bastian B, Ihn H, Kageshita T. Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma. Br J Dermatol. 2008 Feb; 158(2):411-3. PMID: 17999703.
      View in: PubMed
    91. Bauer J, Bastian B. [DNA copy number changes in the diagnosis of melanocytic tumors]. Pathologe. 2007 Nov; 28(6):464-73. PMID: 17882420.
      View in: PubMed
    92. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg. 2007 Sep; 246(3):466-70; discussion 470-1. PMID: 17717450; PMCID: PMC1959359.
    93. Curtin JA, Pinkel D, Bastian B. Absence of PDGFRA mutations in primary melanoma. J Invest Dermatol. 2008 Feb; 128(2):488-9. PMID: 17762857.
      View in: PubMed
    94. Bastian B, Pinkel D. Expanding the genetic spectrum of pigmentation. Pigment Cell Melanoma Res. 2008 Oct; 21(5):507-8. PMID: 18721233.
      View in: PubMed
    95. Kim RD, Curtin JA, Bastian B. Lack of somatic alterations of MC1R in primary melanoma. Pigment Cell Melanoma Res. 2008 Oct; 21(5):579-82. PMID: 18761657; PMCID: PMC2825252.
    96. Murata H, Ashida A, Takata M, Yamaura M, Bastian B, Saida T. Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas. Cancer Sci. 2007 Jul; 98(7):958-63. PMID: 17488338.
      View in: PubMed
    97. Thorns C, Bastian B, Pinkel D, Roydasgupta R, Fridlyand J, Merz H, Krokowski M, Bernd HW, Feller AC. Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: A matrix-based CGH approach. Genes Chromosomes Cancer. 2007 Jan; 46(1):37-44. PMID: 17044049.
      View in: PubMed
    98. Dumaz N, Hayward R, Martin J, Ogilvie L, Hedley D, Curtin JA, Bastian B, Springer C, Marais R. In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res. 2006 Oct 1; 66(19):9483-91. PMID: 17018604.
      View in: PubMed
    99. Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, Kaufman RJ, Bastian B, Soengas MS. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol. 2006 Oct; 8(10):1053-63. PMID: 16964246.
      View in: PubMed
    100. Curtin JA, Busam K, Pinkel D, Bastian B. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006 Sep 10; 24(26):4340-6. PMID: 16908931.
      View in: PubMed
    101. Bauer J, Curtin JA, Pinkel D, Bastian B. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol. 2007 Jan; 127(1):179-82. PMID: 16888631.
      View in: PubMed
    102. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian B. MC1R germline variants confer risk for BRAF-mutant melanoma. Science. 2006 Jul 28; 313(5786):521-2. PMID: 16809487.
      View in: PubMed
    103. Curtin JA, Stark MS, Pinkel D, Hayward NK, Bastian B. PI3-kinase subunits are infrequent somatic targets in melanoma. J Invest Dermatol. 2006 Jul; 126(7):1660-3. PMID: 16614723.
      View in: PubMed
    104. Bauer J, Bastian B. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther. 2006 Jan-Feb; 19(1):40-9. PMID: 16405569.
      View in: PubMed
    105. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian B. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005 Nov 17; 353(20):2135-47. PMID: 16291983.
      View in: PubMed
    106. Maize JC, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian B. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005 Sep; 29(9):1214-20. PMID: 16096412.
      View in: PubMed
    107. Sahara LY, Bastian B, Bruckner AL. Coalescing, nevoid papules in an infant. Arch Dermatol. 2005 Jul; 141(7):897-902. PMID: 16027310.
      View in: PubMed
    108. Bauer J, Bastian B. Genomic analysis of melanocytic neoplasia. Adv Dermatol. 2005; 21:81-99. PMID: 16350439.
      View in: PubMed
    109. Hantschke M, Bastian B, LeBoit PE. Consumption of the epidermis: a diagnostic criterion for the differential diagnosis of melanoma and Spitz nevus. Am J Surg Pathol. 2004 Dec; 28(12):1621-5. PMID: 15577682.
      View in: PubMed
    110. Bastian B. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis. Pathology. 2004 Oct; 36(5):458-61. PMID: 15370116.
      View in: PubMed
    111. Maldonado JL, Timmerman L, Fridlyand J, Bastian B. Mechanisms of cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase pathway. Am J Pathol. 2004 May; 164(5):1783-7. PMID: 15111324; PMCID: PMC1615645.
    112. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian B. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003 Dec 17; 95(24):1878-90. PMID: 14679157.
      View in: PubMed
    113. Bastian B, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003 Nov; 163(5):1765-70. PMID: 14578177; PMCID: PMC1892437.
    114. Dalton SR, Fillman EP, Altman CE, Gardner TL, Davis TL, Bastian B, Libow LF, Elston DM. Atypical junctional melanocytic proliferations in benign lichenoid keratosis. Hum Pathol. 2003 Jul; 34(7):706-9. PMID: 12874767.
      View in: PubMed
    115. Bastian B. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene. 2003 May 19; 22(20):3081-6. PMID: 12789284.
      View in: PubMed
    116. Bastian B. Hypothesis: a role for telomere crisis in spontaneous regression of melanoma. Arch Dermatol. 2003 May; 139(5):667-8. PMID: 12756110.
      View in: PubMed
    117. Bastian B. The longer your telomeres, the larger your nevus? Am J Dermatopathol. 2003 Feb; 25(1):83-4. PMID: 12544108.
      View in: PubMed
    118. Takata M, Maruo K, Kageshita T, Ikeda S, Ono T, Shirasaki F, Takehara K, Bastian B. Two cases of unusual acral melanocytic tumors: illustration of molecular cytogenetics as a diagnostic tool. Hum Pathol. 2003 Jan; 34(1):89-92. PMID: 12605371.
      View in: PubMed
    119. Buckley PG, Mantripragada KK, Benetkiewicz M, Tapia-Páez I, Diaz De Ståhl T, Rosenquist M, Ali H, Jarbo C, De Bustos C, Hirvelä C, Sinder Wilén B, Fransson I, Thyr C, Johnsson BI, Bruder CE, Menzel U, Hergersberg M, Mandahl N, Blennow E, Wedell A, Beare DM, Collins JE, Dunham I, Albertson D, Pinkel D, Bastian B, Faruqi AF, Lasken RS, Ichimura K, Collins VP, Dumanski JP. A full-coverage, high-resolution human chromosome 22 genomic microarray for clinical and research applications. Hum Mol Genet. 2002 Dec 1; 11(25):3221-9. PMID: 12444106.
      View in: PubMed
    120. Bastian B, Xiong J, Frieden IJ, Williams ML, Chou P, Busam K, Pinkel D, LeBoit PE. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol. 2002 Oct; 161(4):1163-9. PMID: 12368190; PMCID: PMC1867277.
    121. Sauter ER, Yeo UC, von Stemm A, Zhu W, Litwin S, Tichansky DS, Pistritto G, Nesbit M, Pinkel D, Herlyn M, Bastian B. Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 2002 Jun 1; 62(11):3200-6. PMID: 12036934.
      View in: PubMed
    122. Harvell JD, Bastian B, LeBoit PE. Persistent (recurrent) Spitz nevi: a histopathologic, immunohistochemical, and molecular pathologic study of 22 cases. Am J Surg Pathol. 2002 May; 26(5):654-61. PMID: 11979096.
      View in: PubMed
    123. You MJ, Castrillon DH, Bastian B, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A. 2002 Feb 5; 99(3):1455-60. PMID: 11818530; PMCID: PMC122212.
    124. Bastian B. Molecular cytogenetics as a diagnostic tool for typing melanocytic tumors. Recent Results Cancer Res. 2002; 160:92-9. PMID: 12079244.
      View in: PubMed
    125. Bastian B, LeBoit PE, Pinkel D. Genomic approaches to skin cancer diagnosis. Arch Dermatol. 2001 Nov; 137(11):1507-11. PMID: 11708957.
      View in: PubMed
    126. Polsky D, Bastian B, Hazan C, Melzer K, Pack J, Houghton A, Busam K, Cordon-Cardo C, Osman I. HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma. Cancer Res. 2001 Oct 15; 61(20):7642-6. PMID: 11606406.
      View in: PubMed
    127. Bardeesy N, Bastian B, Hezel A, Pinkel D, DePinho RA, Chin L. Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol. 2001 Mar; 21(6):2144-53. PMID: 11238948; PMCID: PMC86838.
    128. Bastian B, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000 Sep; 157(3):967-72. PMID: 10980135; PMCID: PMC1885704.
    129. Bastian B, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH, Bröcker EB, LeBoit PE, Pinkel D. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res. 2000 Apr 1; 60(7):1968-73. PMID: 10766187.
      View in: PubMed
    130. Bastian B, Wesselmann U, Pinkel D, Leboit PE. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol. 1999 Dec; 113(6):1065-9. PMID: 10594753.
      View in: PubMed
    131. Bastian B, Kutzner H, Yen Ts, LeBoit PE. Signet-ring cell formation in cutaneous neoplasms. J Am Acad Dermatol. 1999 Oct; 41(4):606-13. PMID: 10495385.
      View in: PubMed
    132. Haferkamp B, Bastian B, Bröcker EB, Hamm H. [Pilomatrix carcinoma in an unusual location. Case report and review of the literature]. Hautarzt. 1999 May; 50(5):355-9. PMID: 10412633.
      View in: PubMed
    133. Wesselmann U, Becker LR, Bröcker EB, LeBoit PE, Bastian B. Eosinophilic globules in spitz nevi: no evidence for apoptosis. Am J Dermatopathol. 1998 Dec; 20(6):551-4. PMID: 9855350.
      View in: PubMed
    134. Becker LR, Bastian B, Wesselmann U, Karl S, Hamm H, Bröcker EB. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy. Eur J Dermatol. 1998 Dec; 8(8):551-3. PMID: 9889426.
      View in: PubMed
    135. Bastian B, LeBoit PE, Hamm H, Bröcker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998 May 15; 58(10):2170-5. PMID: 9605762.
      View in: PubMed
    136. Bastian B, Bröcker EB. Adult rhabdomyoma of the lip. Am J Dermatopathol. 1998 Feb; 20(1):61-4. PMID: 9504672.
      View in: PubMed
    137. Bastian B, Ott G, Müller-Deubert S, Bröcker EB, Müller-Hermelink HK. Primary cutaneous natural killer/T-cell lymphoma. Arch Dermatol. 1998 Jan; 134(1):109-11. PMID: 9449926.
      View in: PubMed
    138. Ott G, Bastian B, Katzenberger T, Decoteau JF, Kalla J, Rosenwald A, Weissinger F, Ott MM, Kadin ME, Müller-Hermelink HK. A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation. Br J Haematol. 1998 Jan; 100(1):187-90. PMID: 9450809.
      View in: PubMed
    139. Dummer W, Bröcker EB, Bastian B. Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis. Br J Dermatol. 1997 Aug; 137(2):185-7. PMID: 9292064.
      View in: PubMed
    140. Bastian B, Kreipe HH, Bröcker EB. Primary neuroendocrine carcinoma of the skin with an unusual follicular lymphocytic infiltrate of the dermis. Am J Dermatopathol. 1996 Dec; 18(6):625-8. PMID: 8989938.
      View in: PubMed
    141. Spatz A, Ruiter D, Hardmeier T, Renard N, Wechsler J, Bailly C, Avril MF, Kwee H, Bastian B, Hill C, De Potter C, Prade M. Melanoma in childhood: an EORTC-MCG multicenter study on the clinico-pathological aspects. Int J Cancer. 1996 Nov 4; 68(3):317-24. PMID: 8903473.
      View in: PubMed
    142. Schmidt E, Bastian B, Dummer R, Tony HP, Bröcker EB, Zillikens D. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res. 1996 Jun; 288(7):353-7. PMID: 8818181.
      View in: PubMed
    143. Dummer W, Bastian B, Ernst N, Schänzle C, Schwaaf A, Bröcker EB. Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int J Cancer. 1996 May 29; 66(5):607-10. PMID: 8647620.
      View in: PubMed
    144. Bastian B, Harms D, Kreipe HH, Hamm H, Bröcker EB. [Giant cell fibroblastoma. A rare soft tissue tumor in childhood]. Hautarzt. 1996 Apr; 47(4):299-303. PMID: 8655316.
      View in: PubMed
    145. Rank C, Bastian B, Pistner H, Bröcker EB, Hamm H. [Microcystic adnexal carcinoma of the skin. An underestimated tumor]. Hautarzt. 1996 Apr; 47(4):284-8. PMID: 8655313.
      View in: PubMed
    146. Bastian B, Schacht RJ, Kämpgen E, Bröcker EB. Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha. Arch Dermatol Res. 1996 Mar; 288(3):147-52. PMID: 8967783.
      View in: PubMed
    147. Schmidt E, Ambach A, Bastian B, Bröcker EB, Zillikens D. Elevated levels of interleukin-8 in blister fluid of bullous pemphigoid compared with suction blisters of healthy control subjects. J Am Acad Dermatol. 1996 Feb; 34(2 Pt 1):310-2. PMID: 8642104.
      View in: PubMed
    148. Dummer W, Blaheta HJ, Bastian B, Schenk T, Bröcker EV, Remy W. Preoperative characterization of pigmented skin lesions by epiluminescence microscopy and high-frequency ultrasound. Arch Dermatol. 1995 Mar; 131(3):279-85. PMID: 7887656.
      View in: PubMed
    149. Bastian B, Nuss B, Römisch J, Kraus M, Bröcker EB. Autoantibodies to annexins: a diagnostic marker for cutaneous disorders? J Dermatol Sci. 1994 Dec; 8(3):194-202. PMID: 7865477.
      View in: PubMed
    150. Drepper H, Köhler CO, Bastian B, Breuninger H, Bröcker EB, Göhl J, Groth W, Hermanek P, Hohenberger W, Kölmel K. [Prognostic advantage for defined risk groups by lymphocyte dissection. Long-term study of 3,616 melanoma patients]. Hautarzt. 1994 Sep; 45(9):615-22. PMID: 7960769.
      View in: PubMed
    151. Breuninger H, Köhler C, Drepper H, Bastian B, Bröcker EB, Göhl J, Groth W, Hermanek P, Hohenberger W, Lippold A. [Is acrolentiginous melanoma (ALM) more malignant than superficially spreading melanoma (SSM) at a high-risk site? A matched-pair comparison between 113 ALM and SSM within the scope of a multicenter study]. Hautarzt. 1994 Aug; 45(8):529-31. PMID: 7960751.
      View in: PubMed
    152. Bastian B, Küchler A, Bröcker EB. [Benign giant cell tumor of the tendon sheath. A differential diagnosis of cutaneous tumors near the joint]. Hautarzt. 1994 Jun; 45(6):385-8. PMID: 8071069.
      View in: PubMed
    153. Bastian B, van der Piepen U, Römisch J, Pâques EP, Bröcker EB. Localization of annexins in normal and diseased human skin. J Dermatol Sci. 1993 Dec; 6(3):225-34. PMID: 8136320.
      View in: PubMed
    154. Bastian B, Sellert C, Seekamp A, Römisch J, Pâques EP, Bröcker EB. Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. J Invest Dermatol. 1993 Sep; 101(3):359-63. PMID: 8370974.
      View in: PubMed
    155. Drepper H, Köhler CO, Bastian B, Breuninger H, Bröcker EB, Göhl J, Groth W, Hermanek P, Hohenberger W, Lippold A. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer. 1993 Aug 1; 72(3):741-9. PMID: 8334626.
      View in: PubMed
    Boris's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP